Increased levels of Reelin in human AD CSF appear at the early stages of the disease which might be the result of disrupted ApoER signaling or a compensatory mechanism to protect synapses (Sáez-Valero et al., 2003; Botella-López et al., 2006; Lopez-Font et al., 2019). This evidence concerns the gene RELN and Alzheimer disease.